Home » Topics » BioWorld Science

BioWorld Science
RSS

Approval of Pulmozyme recommended for new indication

Oct. 11, 1996

Treatment for cystic fibrosis patients progresses on schedule

Oct. 11, 1996

Dual thromboxane synthase/lipoxygenase inhibitors from Nikken Chemicals

Oct. 11, 1996

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

Yamanouchi's CNS products in the pipeline

Oct. 11, 1996

Novel treatment for chronic fatigue syndrome available in Canada

Oct. 11, 1996

Novel free radical-scavenging and neuroprotective substance isolated by Japanese researchers

Oct. 11, 1996

Calpain inhibitors reported by Warner-Lambert

Oct. 11, 1996

New muscarinic antagonists from Schering-Plough

Oct. 11, 1996

Copaxone approvable for MS

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 13, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026